Article Versions Notes

Ton A-T, Foo J, Singh K, Lee J, Kalyta A, Morin H, Perez C, Ban F, Leblanc E, Lallous N, et al. Development of VPC-70619, a Small-Molecule N-Myc Inhibitor as a Potential Therapy for Neuroendocrine Prostate Cancer. International Journal of Molecular Sciences. 2022; 23(5):2588. https://doi.org/10.3390/ijms23052588

Ton, Anh-Tien, Jane Foo, Kriti Singh, Joseph Lee, Anastasia Kalyta, Helene Morin, Carl Perez, Fuqiang Ban, Eric Leblanc, Nada Lallous, and et al. 2022. "Development of VPC-70619, a Small-Molecule N-Myc Inhibitor as a Potential Therapy for Neuroendocrine Prostate Cancer" International Journal of Molecular Sciences 23, no. 5: 2588. https://doi.org/10.3390/ijms23052588

Ton, A. -T., Foo, J., Singh, K., Lee, J., Kalyta, A., Morin, H., Perez, C., Ban, F., Leblanc, E., Lallous, N., & Cherkasov, A. (2022). Development of VPC-70619, a Small-Molecule N-Myc Inhibitor as a Potential Therapy for Neuroendocrine Prostate Cancer. International Journal of Molecular Sciences, 23(5), 2588. https://doi.org/10.3390/ijms23052588